BioWales 2010 Programme
Day 1: Wednesday, 17th March 2010
| Time | Event | Speaker | Title & Company |
|---|---|---|---|
| 08.30 - 14.00 | Registration and coffee | ||
| 09.00 - 18.00 | Biopartnering Event and Exhibition | ||
| 09.00 - 12.00 | Workshops | ||
| 12.00 - 13.10 | Lunch | ||
| 13.15 - 13.30 | Opening address | First Minister Carwyn Jones | |
| 13.30 - 13.45 | Introduction Welsh life science sector |
Gwyn Tudor |
MediWales |
| 13.45 - 14.20 | Point of Care Diagnostics Novel sensing technology for point of care diagnostics | Dr. Peter Laitenberger | VP Research and Technology Development, Sphere Medical |
| 14.20 - 14.50 | Application of point of care diagnostics in personalised medicine | Berwyn Clarke | Chief Scientific Officer, Lab 21 |
| 14.50 - 15.20 | Nanotechnology reagents for future point of care diagnostics- steps to successful commercialisation | Peter Corish | CEO, BBI Life Sciences |
| 15.20 - 15.45 | Coffee/Tea Break | ||
15.45 - 16.15 |
Stem Cells- Industrialisation for drug development and therapy
Therapeutic and research potential of human stem cells |
Stephen Minger |
Head of Research and Development for Cell Technologies, GE Healthcare |
| 16.15 - 16.45 | Stem cell and therapy | Profesor Sir Martin Evans/ Ajan Reginald | Chief Scientific Officer/ CEO Cell Therapy Ltd |
| 16.45 - 17.15 | Scaling human embryonic stem cell-derived therapeutics manufacturing | Anthony Davies | VP Product Development, Geron |
| 17.15 - 18.00 | Key Note Speaker Research funders and the Biotech industry; a case for better partnership | John Jeans | Chief Operating Officer & Deputy Chief Executive MRC |
| 19.00 - 19.45 | Pre-Dinner drinks | ||
| 19.45 - 22.30 | BioWales dinner |
Day 2: Thursday, 18th March 2010
| Time | Event | Speaker | Title |
|---|---|---|---|
| 09.00 - 17.00 | Biopartnering Event and Exhibition | ||
| 09.00 - 09.15 | Cancer Session
Applying advances in cancer genetics |
Julian Sampson |
Head of Department, Medical Genetics, Cardiff University |
| 09.15 - 09.30 | New technologies for developing cancer risk diagnostics and cancer therapeutics | Ray Waters | Head of Cancer Studies, Cardiff Medial School |
| 09.30 - 09.50 | Q-Sphera TM, a new drug scene on Newport Road | Jo Macpherson | Chief Scientific Officer, Q-Chip |
| 09.50 - 10.05 | Future Watch Calon Cardio-technology
| Graham Foster | Technical Director, Calon Cardio |
| 10.05 - 10.20 | Challenges of prostate cancer screening | Mark Fisher | Director, Oncomorph |
| 10.20 - 10.35 | Ocelus micro-implants: small, clever medication | Andrew Kirby | Director, Ocelus |
10.35 - 11.05
11.05 - 11.15 | Coffee/Tea Break
Translational Research Grappling with translation |
Julian Hopkin |
Rector of Medicine and Health, Swansea University |
| 11.15 - 11.45 | Translational research networks accross universities. The Bristol-Cardiff experience | Lars Sandstrom | Director, SATRE |
| 11.45 - 12.15 | Addressing challenges in the medicine and health technology sectors | Zahid Latif | Lead Specialist Medicines and Healthcare, Technology Strategy Board |
| 12.15 - 12.45 | Larval therapy a new medicine for the care of chronic wounds | Alan Morgan | R&D Director, Zoobiotic |
| 12.45 - 13.00 | Question and answer session, summation of the two day event | Bob Wallis | On behalf of the Welsh Assembly Government |
| 13.00 - 14.00 | Lunch | ||
| 13.30 - 17.00 | Workshops |